Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease

NCT03543540 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease
Intestinal Disease
Malabsorption Syndromes
Gastrointestinal Disease
Digestive System Diseases
Metabolic Disease
Coeliac Disease
Gluten Sensitivity

Interventions

BIOLOGICAL: Nexvax2
BIOLOGICAL: Placebo

Sponsor

ImmusanT, Inc.